Skip to main navigation Skip to search Skip to main content

A multi center open label extension study to evaluate the long term safet and tolerability of oral ubrogepant in the acute treatment of migraine with or without aura in children and adolescents ages 6-17

Upstate Medical University

Project: Research

Project Details

StatusActive
Effective start/end date08/11/22 → 08/10/26

Funding

  • AbbVie Incorporated: $110,164.90